CD58 and paraganglioma: Similarly, CD58 correlated with MSI in breast invasive carcinoma (BRCA), CESC, KICH, LUAD, ovarian serous cystadenocarcinoma (OV), pheochromocytoma and paraganglioma (PCPG), THCA, and UCEC.